Pursuant to the Regulation 30 of the of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Vivanza Biosciences has informed that Hemant Amrish Parikh (DIN: 00027820) vide his letter dated March 17th, 2026 has tendered his Resignation as a Non-Executive Director of the Company with effect from the close of business hours on March 17th, 2026 due to personal reasons. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026, last amended on January 30, 2026, are given as Annexure A. Further, the Company has received confirmation from Hemant Amrish Parikh (DIN: 00027820) that there are no material reasons for his resignation other than those mentioned in his resignation letter dated March 17th, 2026 and the same is enclosed as Annexure-B.

The above information is a part of company’s filings submitted to BSE.